Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jun 23, 2009

Premium

CLC Bio plans to release CLC Genomics Machine at a conference later this week, a "turnkey solution" for analyzing and visualizing next-generation sequencing data. The product consists of a hardware platform, several pre-installed software tools, including accelerated algorithms for next-generation sequencing data analysis, and an enterprise-level database.

The system includes a de novo assembly algorithm that enables assemblies of human and large plant genomes in a short time, according to the firm. Internal performance-benchmark studies have shown the system can generate a reference assembly of a human genome sequenced at one-fold coverage in about one hour. CLC Genomics Machine also includes other algorithms, like BLASTp, BLASTn, hmmsearch, hmmpfam, Smith-Waterman, and ClustalW.


Life Technologies division Applied Biosystems has launched the SOLiD Whole Transcriptome Analysis Kit, which enables the detailed characterization of all expressed RNA using the SOLiD sequencing platform. The kit, which combines Ambion reagents from Life Tech's Invitrogen brand with the SOLiD system, has already been used by researchers at the Beijing Institute of Genomics of the Chinese Academy of Sciences, according to ABI, to study expression profiles of multiple tissues and cells in human, mouse, rice, and microbes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more